Abdominal Wall Closure With Triclosan-coated Suture

Infection Clinical Trial

— TCS09  

Official title:

Abdomen Closure Using Triclosan Coated Absorbable Suture vs Uncoated Sutures of the Same Base Material

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01620294
• Other study ID #: triclosan-coated-suture2009
• Status: Completed
• Phase: Phase 3
• First received: May 10, 2010
• Last updated: June 14, 2012
• Start date: November 2009
• Est. completion date: November 2010

Study information

• Verified date: June 2012
• Source: University of Pecs
• Contact: n/a
• Is FDA regulated: No
• Health authority: Hungary: Institutional Ethics Committee
• Study type: Interventional

Clinical Trial Summary

After open colorectal surgery the surgical site infection (SSI) is very high among abdominal surgeries. The goal of the investigators randomized, prospective, multicentric, internet-based study is to compare rate of SSI after surgery of colon and rectum by using triclosan-coated suture for abdominal wall closure. 180-180 cases in seven centres are involved in this study. Two arms are separated by computer randomization at abdominal wall closure: application of triclosan-coated and non-coated PDS suture (PDS versus PDS-Plus). Triclosan is an antiseptic material which the investigators hope will provide better local infection control at the site with reducing the risk of bacterial colonisation.

Description:

After open colorectal surgery the surgical site infection (SSI) is very high among abdominal surgeries. The goal of our randomized, prospective, multicentric, internet-based study is to compare rate of SSI after surgery of colon and rectum by using triclosan-coated suture for abdominal wall closure. Two arms are separated by computer randomization at abdominal wall closure: application of triclosan-coated and non-coated PDS suture (PDS versus PDS-Plus). Triclosan is an antiseptic material which we hope provides better local infection control at the site with reducing the risk of bacterial colonisation.

attached website: www.itplan.hu/sebstudy/ Randomizing patients: 1. logging in (completing the ID panel) 2. on-line randomization 3. patient appears on list 4. operation (recording details) 5. recording - post-operation events

• complications

• control examination

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1
• Est. completion date: November 2010
• Est. primary completion date: April 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Elective (subjected to bowel preparation) operations

• Benign or malignant colon or rectal disease

• Age: 18-80

• Bowel opening is made during operation

Exclusion Criteria:

1. Cannot be randomized:

• Systemic diseases influencing local surgical site healing

• Insulin-dependent diabetes mellitus

• Child B-C liver cirrhosis

• Kidney disease requiring dialysis

• Immune-suppression treatment

• IBD

• Acute surgery or unprepared bowel

• After being informed patient does not sign the statement of consent

2. To be excluded later:

• Surgically incurable tumour

• Septic state or complication occurred in the post-operational stage

• Patient withdraws the signed consent before the examination is closed

3. Undesirable complication:

• Sterile surgical site separation

• Suture break during the post-operational stage

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Infection

Intervention

Procedure:
• abdominal wall closure
triclosan-coated (PDS-Plus) and non-coated (PDS) suture to close the abd. wall
• surgical site infection
triclosan-coated (PDS-Plus) and non-coated (PDS) suture to close the abd. wall

Locations

Country	Name	City	State
Hungary	Department of Surgery Medical Faculty, University of Pecs, Hungary	Pecs

Sponsors (1)

Lead Sponsor	Collaborator
University of Pecs

Country where clinical trial is conducted

Hungary, 

References & Publications (8)

Barbolt TA. Chemistry and safety of triclosan, and its use as an antimicrobial coating on Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan). Surg Infect (Larchmt). 2002;3 Suppl 1:S45-53. Review. — View Citation

Fleck T, Moidl R, Blacky A, Fleck M, Wolner E, Grabenwoger M, Wisser W. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg. 2007 Jul;84(1):232-6. Erratum in: Ann Thorac Surg. 2007 Dec;84(6):2139. — View Citation

Justinger C, Moussavian MR, Schlueter C, Kopp B, Kollmar O, Schilling MK. Antibacterial [corrected] coating of abdominal closure sutures and wound infection. Surgery. 2009 Mar;145(3):330-4. doi: 10.1016/j.surg.2008.11.007. Epub 2009 Jan 25. Erratum in: Surgery. 2009 Sep;146(3):468. — View Citation

Kobayashi M, Mohri Y, Inoue Y, Okita Y, Miki C, Kusunoki M. Continuous follow-up of surgical site infections for 30 days after colorectal surgery. World J Surg. 2008 Jun;32(6):1142-6. doi: 10.1007/s00268-008-9536-6. — View Citation

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80. — View Citation

Nichols RL, Choe EU, Weldon CB. Mechanical and antibacterial bowel preparation in colon and rectal surgery. Chemotherapy. 2005;51 Suppl 1:115-21. Review. — View Citation

Nishikawa K, Hanyuu N, Yuda M, Tanaka Y, Matsumoto A, Yasue H, Hayashi T, Kawano S, Usuba T, Iino T, Mizuno R, Iwabuchi S. How can we control intraoperative bacterial contamination and surgical-site infection during an anterior resection or Hartmann's/Miles' operation? J Gastrointest Surg. 2008 Nov;12(11):1995-2000. doi: 10.1007/s11605-008-0582-z. Epub 2008 Jul 18. — View Citation

Watanabe A, Kohnoe S, Shimabukuro R, Yamanaka T, Iso Y, Baba H, Higashi H, Orita H, Emi Y, Takahashi I, Korenaga D, Maehara Y. Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Surg Today. 2008;38(5):404-12. doi: 10.1007/s00595-007-3637-y. Epub 2008 Apr 30. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	quality and quantity of wound discharge		30 days	No
Secondary	number of applied different types of bandages		30 days	No
Secondary	charges of wound care		30 days	No

External Links

•   website is in Hungarian, secured by an independent officer